|
1. |
RELATIONSHIP BETWEEN THE CHANGES IN SERUM THYROID HORMONE LEVELS AND PROTEIN STATUS DURING PROLONGED PROTEIN SUPPLEMENTED CALORIC DEPRIVATION |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 1-15
ELAINE M. KAPTEIN,
JANIS S. FISLER,
MARYSIA J. DUDA,
J. T. NICOLOFF,
E. J. DRENICK,
Preview
|
PDF (837KB)
|
|
摘要:
SUMMARYThe relationship between the changes in serum thyroid hormone levels and nitrogen economy during caloric deprivation were investigated in ten obese men during a 40 d, 400 kcal protein‐supplemented weight‐reducing diet. This regimen induced increases in the serum levels of total T4, free T4 and total rT3, and decreases of total T3, while serum TSH remained unchanged. There were progressive decreases in total body weight and urinary losses of total nitrogen and 3‐methylhistidine, with the early negative nitrogen balance gradually returning towards basal values during the 40 days. Subjects with the largest weight loss had the most increase in the serum levels of total T4 and free T4 index and the greatest decrease in T3. The magnitude of the increase of the nitrogen balance from its nadir was correlated with the extent of the reduction of T3 and increase of T3 uptake ratio and free T4 levels. The decrease in the urinary excretion of 3‐methylhistidine correlated with the increase in free T4 and rT3 levels. Nadir serum transferrin values were directly related to peak rT3 values, and the lowest albumin concentrations occurred in subjects with the highest total T4 and free T4 index values. Further, the maximum changes in the serum thyroid hormone levels preceded those of the nutritional parameters. These relationships suggest that: (1) increases in serum rT3 and free T4 and reductions in T3 concentrations during protein supplemented weight reduction may facilitate conservation of visceral protein and reduce muscle protein turnover; and (2) the variation in the magnitude of these changes may account for the heterogeneity of nitrogen
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01059.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
2. |
MULTIPLE INTRACRANIAL METASTASES FROM A PROLACTIN SECRETING PITUITARY TUMOUR |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 17-27
R. W. GASSER,
G. FINKENSTEDT,
F. SKRABAL,
K. TWERDY,
V. GRUNERT,
U. MAYR,
H. FROMMHOLD,
D. NEDDEN,
J. FEICHTINGER,
F. HOFSTAEDTER,
Preview
|
PDF (2668KB)
|
|
摘要:
SUMMARYA 28 year old man presented with partial hypopituitarism and signs of a pituitary tumour. A chromophobe adenoma was partially removed by right frontal craniotomy. Seven years later complete hypopituitarism and hyperprolactinaemia were documented, at which time there was no evidence of tumour recurrence on CT scan. The patient was treated with bromocriptine but the pituitary tumour redeveloped a year later. Nine years after the original operation the first metastasis was demonstrated together with very high prolactin levels. The intracranial metastasis, and the pituitary tumour were removed at a second craniotomy following which the prolactin concentration fell. Further metastases developed subsequently and the patient died 12 years after the initial diagnosis. At autopsy multiple metastases were found in the brain, tumour cells were present in the subarachnoid space and in cerebral veins. The pituitary tumour and secondaries were shown by immunocytochemistry to contain prolactin but not ACTH or growth hormone. This appears to be the third well documented case of a metastasizing, prolactin secreting pituitary tumour.
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01060.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
3. |
THE TREATMENT OF HIRSUTISM WITH A COMBINATION OF DESOGESTREL AND ETHINYL OESTRADIOL |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 29-36
P. DEWIS,
P. PETSOS,
M. NEWMAN,
D. C. ANDERSON,
Preview
|
PDF (485KB)
|
|
摘要:
SUMMARYSome available oral contraceptive agents are unsuitable for the treatment of hirsutism since, although they suppress endogenous gonadotrophins and so ovarian androgen production, they contain a progestogen which is itself androgenic. The combination of 30 μg ethinyl oestradiol (EE2) and 150 μg desogestrel (Marvelon) does not suffer from this drawback. We have therefore assessed its value in 15 hirsute women treated for one year. Mean±SE androgen‐dependent hair growth, assessed photographically fell from 0·31 ± 0·01 to 0·23 ± 0·01 mm/d at 1 year (P<0·001). Ten of the fifteen patients reported definite subjective improvement. Treatment was associated with a marked rise in SHBG concentration identical to that seen with 30 μg EE2 alone. By four months there were significant falls in serum levels of androstenedione and LH throughout the cycle, but not for testosterone, dihydrotestosterone or 5α‐androstane 3α, β17 ‐diol. Calculated free testosterone levels were significantly suppressed. All the biochemical changes were maintained after seven months of treatment. We conclude that this preparation is a suitable oral contraceptive for the treatme
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01061.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
4. |
VARIATION IN OSMOREGULATION OF ARGININE VASOPRESSIN DURING THE HUMAN MENSTRUAL CYCLE |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 37-42
B. A. SPRUCE,
P. H. BAYLIS,
J. BURD,
M. J. WATSON,
Preview
|
PDF (362KB)
|
|
摘要:
SUMMARYOsmoregulation of vasopressin secretion was studied in eight healthy women in the follicular and luteal phases of the menstrual cycle. Basal plasma osmolality in the luteal phase was significantly lower than in the follicular period (282·4±0·6, 285·6 ± 1·1 mmol/kg, respectively,P<0·05). Plasma AVP (pAVP) and plasma osmolality (pOsm) were measured during the infusion of 850 mmol/1 saline in both phases of the cycle, and linear regression analyses of these data gave the following regression equations (i) follicular, pAVP = 0·43 (pOsm‐284),r=+0·93, (ii) luteal, pAVP = 0·31 (pOsm‐279),r=+0·95. Both the slope and abscissal intercept were significantly different (P<0·01). Osmotic threshold for thirst sensation in the luteal phase was lower than the follicular (293±2, 297±1 mmol/kg,P<0·005). We conclude that, in the luteal phase, the threshold for AVP release and the gain or sensitivity of the osmostat are reduced together with lowering of the thirst threshold, which account for the lower basal luteal
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01062.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
5. |
GONADOTROPHIN‐SECRETING PITUITARY TUMOUR: REPORT AND REVIEW |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 43-48
M. D. WHITAKER,
J. C. PRIOR,
B. SCHEITHAUER,
L. DOLMAN,
F. DURITY,
M. R. PUDEK,
Preview
|
PDF (376KB)
|
|
摘要:
SUMMARYA 34‐year‐old male with a pituitary adenoma was investigated and demonstrated to have hypersecretion of both gonadotrophins in the basal state. Immunocytochemical staining and electron microscopic examination were positive for tumour cells secreting FSH and LH. Presenting symptoms included visual disturbances, loss of libido, impotence, cold intolerance, frontal headaches, change in skin pigmentation and excessive weight gain. The patient denied alteration in hair distribution, had no acral features, galactorrhoea or gynaecomastia. Surgical extirpation resulted in complete amelioration of his symptoms over a three year follow‐up period. Basal and stimulated pituitary function testing results returned to normal post‐operatively. A review of the literature documents six other cases of pituitary tumour secreting both LH and FSH in the basal state. More commonly, the pituitary adenoma secretes FSH only. The literature is reviewed with regard to both types of
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01063.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
6. |
EVIDENCE FOR THE PARTICIPATION OF ENDOGENOUS OPIOIDS IN THE SYMPATHOADRENAL RESPONSE TO HYPOGLYCAEMIA IN MAN |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 49-56
P‐M. G. BOULOUX,
A. GROSSMAN,
N. LYTRAS,
G. M. BESSER,
Preview
|
PDF (451KB)
|
|
摘要:
SUMMARYThe effects of the long acting met‐enkephalin analogued‐Ala2‐MePhe4‐met‐enkephalin‐O‐ol (DAMME) and the opiate antagonist naloxone on the plasma catecholamine responses to insulin‐induced hypoglycaemia have been investigated in two separate studies. DAMME depressed basal noradrenaline and adrenaline at 15 min, and blunted both the noradrenaline and adrenaline responses to hypoglycaemia. Naloxone did not alter basal plasma catecholamines, but caused a significant enhancement of the adrenaline response to hypoglycaemia. Neither DAMME nor naloxone altered the blood glucose response to insulin‐induced hypoglycaemia. These data are consistent with an inhibitory modulation of endogenous opioids in the sympathoadrenal response to insulin‐induced h
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01064.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
7. |
THE ABSENCE OF ANY EFFECT OF METHIMAZOLE ON IN VITRO CELL‐MEDIATED CYTOTOXICITY |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 57-64
A. P. WEETMAN,
CATHERINE GUNN,
R. HALL,
A. M. McGREGOR,
Preview
|
PDF (457KB)
|
|
摘要:
SUMMARYTwo recent studies have reported that antithyroid drugs inhibit killer (K) and natural killer (NK) cell functionin vitro, which could be relevant to the changes in these cell populations during treatment of GRAVES' disease. In contrast to these reports we have found noin vitroeffect of pharmacologically relevant concentrations of methimazole (MMI) (100 μmol/l) on (i) NK cell function using K562 cells or MOLT‐4 cells as targets, (ii) K cell function using antibody‐dependent cytotoxicity assays with L929 cells or thyroid‐antigen‐coated chick red cells, or (iii) monocyte‐dependent cytotoxin‐mediated killing of L929 cells. Enhanced cytotoxicity was found with 1 mmol/l MMI in some of these assays but this was not consistent since it occurred only in certain individual cultures. Since we have shown previously that 100 μmol/l MMI inhibits oxygen radical generation, the present results add to the evidence that these radicals are not directly involved in cell‐mediated cytotoxicity and do not support the concept that antithyroid drugs have a significant effect on antibody‐dependent cell‐mediated cytotoxicity
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01065.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
8. |
BIOACTIVE FORMS OF SERUM LACTOGENS: EFFECTS OF TREATMENT OF PROLACTINOMA PATIENTS WITH BROMOCRIPTINE |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 65-73
P. S. RENNIE,
J. C. PRIOR,
N. BRUCHOVSKY,
P. W. GOUT,
Preview
|
PDF (484KB)
|
|
摘要:
SUMMARYAnin vitrobioassay for lactogenic hormones, based on the specific mitogenic effects of lactogens on cultured Nb2 node rat lymphoma cells, was used to measure the levels of lactogens in whole serum and in fractionated serum samples from three patients with prolactin (PRL) secreting pituitary adenomas. Under basal conditions, after pituitary stimulation, and following treatment with bromocriptine which greatly decreased the serum PRL levels, the bioassay (BA) results closely paralleled fluctuations in the sum of radioimmunoassay (RIA) estimates of serum PRL and growth hormone concentrations. The extreme sensitivity (10 pg/ml) of the BA facilitated measurement of PRL in fractions obtained after Sephadex G‐100 chromatography of only 0·1 to 0·3 ml of sera from both untreated and bromocriptine‐treated prolactinoma patients. In both types of samples, similar heterogenous patterns of bioactive PRL were observed, although most of the recovered activity appeared to be due to monomeric PRL. BA and RIA of fractions obtained after DEAE cellulose chromatography of sera from untreated prolactinoma patients revealed two PRL peaks, the first one containing 75% of the activity. Therapy with bromocriptine led to a reduction in the total serum PRL activity and, in particular, in the activity of the second
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01066.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
9. |
EVIDENCE FOR DIFFERING DOPAMINERGIC ACTIVITY IN CHILDHOOD‐ OR ADULT‐ONSET OBESITY |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 75-81
ANNA CATANIA,
L. CANTALAMESSA,
EMANUELA VENEGONI,
ALESSANDRA ORSATTI,
MARINA BALDINI,
C. ZANUSSI,
Preview
|
PDF (366KB)
|
|
摘要:
SUMMARYIn order to investigate dopaminergic activity in two types of human obesity, childhood‐ and adult‐onset, we have studied the responses of plasma TSH and prolactin to domperidone, a dopamine receptor antagonist, in 12 patients obese since early childhood, 12 patients with adult‐onset obesity, and in 12 lean controls. All subjects were females. In childhood‐onset obese patients the responses of plasma prolactin and TSH to antidopaminergic stimulation were lower than those of adult‐onset obese patients and lean controls. Conversely, the stimulus elicited a normal response of plasma prolactin and an exaggerated response of plasma TSH in adult‐onset obese patients. These data indicate the presence of differing dopaminergic tone in the two types of hu
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01067.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
10. |
END‐ORGAN RESPONSES TO THYROXINE THERAPY IN SUBCLINICAL HYPOTHYROIDISM |
|
Clinical Endocrinology,
Volume 22,
Issue 1,
1985,
Page 83-89
G. M. BELL,
W. T. A. TODD,
J. C. FORFAR,
C. MARTYN,
C. G. WATHEN,
S. GOW,
R. RIEMERSMA,
A. D. TOFT,
Preview
|
PDF (433KB)
|
|
摘要:
SUMMARYWe studied variables known to change with thyroid hormone status in 18 patients with subclinical hypothyroidism before and during treatment with thyroxine in a dose sufficient to restore the plasma TSH response to TRH to normal. There was an associated increase in both plasma total T4 and free T4 within the normal range but plasma total T3 and free T3 were unchanged. As a result of thyroxine treatment there was a small but significant increase (P<0.05) in left ventricular ejection fraction (LVEF) with maximal exercise but no significant changes in LVEF at rest and moderate exercise, continuously monitored mean sleeping heart rate, day/night ratios of urinary sodium excretion, peripheral nerve conduction velocities, fasting serum triglycerides, total cholesterol (TC), high density lipoproteins (HDL) or TC/HDL ratios. On this evidence we do not consider that thyroxine replacement therapy is indicated in patients with subclinical hypothyroidism.
ISSN:0300-0664
DOI:10.1111/j.1365-2265.1985.tb01068.x
出版商:Blackwell Publishing Ltd
年代:1985
数据来源: WILEY
|
|